drugset / Trial / NCT03274453

A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion

NCT03274453 ↗

Phase 2 Completed 129 enrolled NYU Langone Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the proposed study is to examine the effectiveness of low dose postoperative ketamine infusion as an analgesic adjuvant to morphine pca in opioid tolerant and opioid naïve patients after major spine surgery. Primary endpoints of the study are to determine the effectiveness of postoperative ketamine infusion in for the reduction of postoperative pain and opioid requirements.

Timeline

Start
2012-11-01
Primary completion
2014-11-01
Completion
2017-09

Outcome

Met primary endpoint

paper Postoperative hydromorphone consumption was significantly reduced in the opioid-tolerant ketamine group, compared with the opioid-tolerant placebo group PMID 30113350 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.12 mg/kg —

Indications

No indication recorded.